LEX-WK-GJW6SBD9crawled 2026-06-26 10:59Z
Ninth Circuit Ruling in FCA Case Predicated on 340B Pricing Violations Has Significant Implications for Pharma Manufacturers
Craig B. Bleifer · Michael J. Podberesky · Jessica L. Vaughn, Ph.D. · The FCA Insider · Published April 6, 2026
Work details
- firm or organization
- McGuireWoods LLP
- publication
- The FCA Insider
- practice area
- Health Care and Life Sciences
- published
- 2026-04-06
Citation
Craig B. Bleifer, Michael J. Podberesky, Jessica L. Vaughn, Ph.D., Ninth Circuit Ruling in FCA Case Predicated on 340B Pricing Violations Has Significant Implications for Pharma Manufacturers , The FCA Insider (April 6, 2026) [The Library at LexBlog, LEX-WK-GJW6SBD9, lexpid.org/GJW6SBD9]